|
|
宫颈高级别上皮内瘤变的筛查与治疗研究进展
|
Abstract:
宫颈癌(CC)是女性第四大恶性肿瘤，是最常见的女性生殖系统恶性肿瘤，每年预估有530,000例新发病例和270,000例死亡病例。子宫颈高级别鳞状上皮内病变(HSIL)是CC的癌前病变，包括宫颈上皮内瘤变Ⅱ级(CIN2)、宫颈上皮内瘤变Ⅲ级(CIN3)。CC是唯一一种可以预防的恶性肿瘤，对HSIL的筛查以及规范治疗是减少浸润性子宫颈癌的重点内容。本研究通过对HSIL的筛查和治疗手段进行综述，以提高对HSIL的认识，推进HSIL防治工作，降低宫颈癌前病变以及CC的发病率。
Cervical cancer (CC) is the fourth largest malignancy in women and the most common malignancy of the female reproductive system, with an estimated 530,000 new cases and 270,000 deaths annually. High-grade squamous intraepithelial lesions (HSIL) are precancerous lesions of CC, including cervical intraepithelial neoplasia grade Ⅱ (CIN2) and cervical intraepithelial neoplasia grade Ⅲ (CIN3). CC is the only malignant tumor that can be prevented. Screening and standard treatment of HSIL is the key to reduce invasive cervical cancer. In this study, the screening and treatment methods of HSIL were reviewed to improve the understanding of HSIL, promote the prevention and treatment of HSIL, and reduce the incidence of cervical precancerous lesions and CC.
| [1] | Huang, J., Deng, Y., Boakye, D., et al. (2022) Global Distribution, Risk Factors, and Recent Trends for Cervical Cancer: A Worldwide Country-Level Analysis. Gynecologic Oncology, 164, 85-92. https://doi.org/10.1016/j.ygyno.2021.11.005 |
| [2] | Guo, M., Xu, J. and Du, J. (2021) Trends in Cervical Cancer Mortality in China from 1989 to 2018: An Age-Period-Cohort Study and Joinpoint Analysis. BMC Public Health, 21, Article No. 1329. https://doi.org/10.1186/s12889-021-11401-8 |
| [3] | Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660 |
| [4] | 张璐, 隋龙. 中国21~24岁女性宫颈癌筛查现状及应对困扰[J]. 现代妇产科进展, 2021, 30(12): 951-953. http://dx.doi.org/10.13283/j.cnki.xdfckjz.2021.12.043 |
| [5] | Basu, P., Taghavi, K., Hu, S.Y., et al. (2018) Management of Cervical Premalignant Lesions. Current Problems in Cancer, 42, 129-136. https://doi.org/10.1016/j.currproblcancer.2018.01.010 |
| [6] | Arbyn, M., Weiderpass, E., Bruni, L., et al. (2020) Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis. The Lancet Global Health, 8, E191-E203. https://doi.org/10.1016/S2214-109X(19)30482-6 |
| [7] | Alfaro, K., Maza, M., Cremer, M., et al. (2021) Removing Global Barriers to Cervical Cancer Prevention and Moving towards Elimination. Nature Reviews Cancer, 21, 607-608. https://doi.org/10.1038/s41568-021-00396-4 |
| [8] | 陈飞, 胡尚英, 李燕, 等. 中国子宫颈癌综合防控路径建设专家共识[J]. 中国预防医学杂志, 2022, 23(10): 721-726. http://dx.doi.org/10.16506/j.1009-6639.2022.10.001 |
| [9] | Ntanasis-Stathopoulos, I., Kyriazoglou, A., Liontos, M., et al. (2020) Current Trends in the Management and Prevention of Human Papillomavirus (HPV) Infection. Journal of BUON: Official Journal of the Balkan Union of Oncology, 25, 1281-1285 |
| [10] | Oyouni, A.A.A. (2023) Human Papillomavirus in Cancer: Infection, Disease Transmission, and Progress in Vaccines. Journal of Infection and Public Health, 16, 626-631. https://doi.org/10.1016/j.jiph.2023.02.014 |
| [11] | Mcbride, A.A. (2022) Human Papillomaviruses: Diversity, Infection and Host Interactions. Nature Reviews Microbiology, 20, 95-108. https://doi.org/10.1038/s41579-021-00617-5 |
| [12] | Zur Hausen, H. (2002) Papillomaviruses and Cancer: From Basic Studies to Clinical Application. Nature Reviews Cancer, 2, 342-350. https://doi.org/10.1038/nrc798 |
| [13] | Hu, Z. and Ma, D. (2018) The Precision Prevention and Therapy of HPV-Related Cervical Cancer: New Concepts and Clinical Implications. Cancer Medicine, 7, 5217-5236. https://doi.org/10.1002/cam4.1501 |
| [14] | Burd, E.M. (2003) Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews, 16, 1-17. https://doi.org/10.1128/CMR.16.1.1-17.2003 |
| [15] | Berti, F.C.B., Salviano-Silva, A., Beckert, H.C., et al. (2019) From Squamous Intraepithelial Lesions to Cervical Cancer: Circulating MicroRNAs as Potential Biomarkers in Cervical Carcinogenesis. Biochimica et Biophysica Acta—Reviews on Cancer, 1872, Article ID: 188306. https://doi.org/10.1016/j.bbcan.2019.08.001 |
| [16] | Bhatla, N. and Singhal, S. (2020) Primary HPV Screening for Cervical Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 65, 98-108. https://doi.org/10.1016/j.bpobgyn.2020.02.008 |
| [17] | Fontham, E.T.H., Wolf, A.M.D., Church, T.R., et al. (2020) Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA: A Cancer Journal for Clinicians, 70, 321-346. https://doi.org/10.3322/caac.21628 |
| [18] | Hu, S.Y., Zhao, X.L., Zhang, Y., et al. (2021) [Interpretation of “WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention, Second Edition”]. Chinese Medical Journal, 101, 2653-2657. |
| [19] | 国家卫生健康委员会. 国家卫生健康委办公厅关于印发宫颈癌筛查工作方案和乳腺癌筛查工作方案的通知(国卫办妇幼函〔2021〕635号) [Z]. 2021. |
| [20] | 李明珠, 魏丽惠, 隋龙, 等. 中国子宫颈癌筛查指南(一) [J]. 中国妇产科临床杂志, 2023, 24(4): 437-442. http://dx.doi.org/10.13390/j.issn.1672-1861.2023.04.029 |
| [21] | Mremi, A., Mchome, B., Mlay, J., et al. (2022) Performance of HPV Testing, Pap Smear and VIA in Women Attending Cervical Cancer Screening in Kilimanjaro Region, Northern Tanzania: A Cross-Sectional Study Nested in a Cohort. BMJ Open, 12, e064321. https://doi.org/10.1136/bmjopen-2022-064321 |
| [22] | Kaban, I., Bacanakgil, B.H. and Koca, S. (2021) The Comparison of Two Methods in Cervical Smear Screening—Which Method Is Better for Smear Adequacy Rates? Ginekologia Polska, 92, 335-338. https://doi.org/10.5603/GP.a2020.0185 |
| [23] | Diamantis, A. and Magiorkinis, E. (2014) Pioneers of Exfoliative Cytology in the 19th Century: The Predecessors of George Papanicolaou. Cytopathology, 25, 215-224. https://doi.org/10.1111/cyt.12074 |
| [24] | Papanicolaou, G.N. and Traut, H.F. (1997) The Diagnostic Value of Vaginal Smears in Carcinoma of the Uterus. 1941. Archives of Pathology & Laboratory Medicine, 121, 211-224. |
| [25] | Zhu, J., Norman, I., Elfgren, K., et al. (2007) A Comparison of Liquid-Based Cytology and Pap Smear as a Screening Method for Cervical Cancer. Oncology Reports, 18, 157-160. https://doi.org/10.3892/or.18.1.157 |
| [26] | Khakwani, M., Parveen, R. and Azhar, M. (2022) Comparison of PAP Smear and Liquid Based Cytology as a Screening Method for Cervical Carcinoma. Pakistan Journal of Medical Sciences, 38, 1827-1831. https://doi.org/10.12669/pjms.38.7.5742 |
| [27] | Park, I.A., Lee, S.N., Chae, S.W., et al. (2001) Comparing the Accuracy of ThinPrep Pap Tests and Conventional Papanicolaou Smears on the Basis of the Histologic Diagnosis: A Clinical Study of Women with Cervical Abnormalities. Acta Cytologica, 45, 525-531. https://doi.org/10.1159/000327859 |
| [28] | Dighe, S.B., Ajit, D., Pathuthara, S., et al. (2006) Papanicolaou Stain: Is It Economical to Switch to Rapid, Economical, Acetic Acid, Papanicolaou Stain? Acta Cytologica, 50, 643-646. https://doi.org/10.1159/000326034 |
| [29] | Liang, L.A., Einzmann, T., Franzen, A., et al. (2021) Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-Alone or Cotesting Strategies. Cancer Epidemiology, Biomarkers & Prevention, 30, 474-484. https://doi.org/10.1158/1055-9965.EPI-20-1003 |
| [30] | Siebers, A.G., Klinkhamer, P.J., Grefte, J.M., et al. (2009) Comparison of Liquid-Based Cytology with Conventional Cytology for Detection of Cervical Cancer Precursors: A Randomized Controlled Trial. JAMA, 302, 1757-1764. https://doi.org/10.1001/jama.2009.1569 |
| [31] | Koliopoulos, G., Nyaga, V.N., Santesso, N., et al. (2017) Cytology versus HPV Testing for Cervical Cancer Screening in the General Population. The Cochrane Database of Systematic Reviews, 8, CD008587. https://doi.org/10.1002/14651858.CD008587.pub2 |
| [32] | Elfstr？m, K.M., Arnheim-Dahlstr？m, L., Von Karsa, L., et al. (2015) Cervical Cancer Screening in Europe: Quality Assurance and Organisation of Programmes. European Journal of Cancer, 51, 950-968. https://doi.org/10.1016/j.ejca.2015.03.008 |
| [33] | Chrysostomou, A.C., Stylianou, D.C., Constantinidou, A. and Kostrikis, L.G. (2018) Cervical Cancer Screening Programs in Europe: The Transition towards HPV Vaccination and Population-Based HPV Testing. Viruses, 10, Article 729. https://doi.org/10.3390/v10120729 |
| [34] | Rozemeijer, K., Penning, C., Siebers, A.G., et al. (2016) Comparing SurePath, ThinPrep, and Conventional Cytology as Primary Test Method: SurePath Is Associated with Increased CIN II Detection Rates. Cancer Causes & Control, 27, 15-25. https://doi.org/10.1007/s10552-015-0678-1 |
| [35] | Zhao, F.H., Hu, S.Y., Bian, J.J., et al. (2011) Comparison of ThinPrep and SurePath Liquid-Based Cytology and Subsequent Human Papillomavirus DNA Testing in China. Cancer Cytopathology, 119, 387-394. https://doi.org/10.1002/cncy.20177 |
| [36] | 李琪. 液基细胞学、阴道镜组织活检和HPV-DNA检测防治宫颈癌前病变的价值研究[J]. 中国妇幼保健, 2018, 33(15): 3578-3580. |
| [37] | Taylor, S., Kuhn, L., Dupree, W., et al. (2006) Direct Comparison of Liquid-Based and Conventional Cytology in a South African Screening Trial. International Journal of Cancer, 118, 957-962. https://doi.org/10.1002/ijc.21434 |
| [38] | Patel, N., Bavikar, R., Buch, A., et al. (2023) A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening. Gynecology and Minimally Invasive Therapy, 12, 77-82. https://doi.org/10.4103/gmit.gmit_118_22 |
| [39] | Davey, E., D’assuncao, J., Irwig, L., et al. (2007) Accuracy of Reading Liquid Based Cytology Slides Using the ThinPrep Imager Compared with Conventional Cytology: Prospective Study. BMJ, 335, 31. https://doi.org/10.1136/bmj.39219.645475.55 |
| [40] | 续薇. 临床细胞病理学诊断报告新方法——TBS诊断标准及要点[J]. 中国实验诊断学, 1999, 3(5): 2. |
| [41] | Pangarkar, M.A. (2022) The Bethesda System for Reporting Cervical Cytology. Cyto Journal, 19, Article 28. https://doi.org/10.25259/CMAS_03_07_2021 |
| [42] | Zhao, C., Crothers, B.A., Tabatabai, Z.L., et al. (2017) False-Negative Interpretation of Adenocarcinoma in Situ in the College of American Pathologists Gynecologic PAP Education Program. Archives of Pathology & Laboratory Medicine, 141, 666-670. https://doi.org/10.5858/arpa.2016-0234-CP |
| [43] | Clarke, M.A., Cheung, L.C., Castle, P.E., et al. (2019) Five-Year Risk of Cervical Precancer Following P16/Ki-67 Dual-Stain Triage of HPV-Positive Women. JAMA Oncology, 5, 181-186. https://doi.org/10.1001/jamaoncol.2018.4270 |
| [44] | Cooper, D.B. and Dunton, C.J. (2023) Colposcopy. StatPearls, Treasure Island. |
| [45] | Khan, M.J., Werner, C.L., Darragh, T.M., et al. (2017) ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice. Journal of Lower Genital Tract Disease, 21, 223-229. https://doi.org/10.1097/LGT.0000000000000338 |
| [46] | Grigore, M., Cruickshank, M.E., Nieminen, P., et al. (2021) National Guidelines for Management of Cervical Squamous Intraepithelial Lesion: A Survey of European Federation for Colposcopy Members. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 256, 46-50. https://doi.org/10.1016/j.ejogrb.2020.10.028 |
| [47] | 彭汝娇, 刘姜伶, 郑诗丹, 等. 阴道镜检查与宫颈电环锥切术在宫颈病变诊治中的应用[J]. 现代妇产科进展, 2016, 25(4): 298-301. http://dx.doi.org/10.13283/j.cnki.xdfckjz.2016.04.015 |
| [48] | 陈哲, 刘文静, 王涛. 阴道镜用于筛查宫颈癌前病变的价值研究[J]. 中国实用医药, 2022, 17(15): 92-94. http://dx.doi.org/10.14163/j.cnki.11-5547/r.2022.15.028 |
| [49] | Egemen, D., Cheung, L.C., Chen, X., et al. (2020) Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. Journal of Lower Genital Tract Disease, 24, 132-143. https://doi.org/10.1097/LGT.0000000000000529 |
| [50] | 赵超, 毕蕙, 赵昀, 等. 子宫颈高级别上皮内病变管理的中国专家共识[J]. 中国妇产科临床杂志, 2022, 23(2): 220-224. http://dx.doi.org/10.13390/j.issn.1672-1861.2022.02.038 |
| [51] | 王红, 徐福智, 赵秋艳. 三阶梯诊疗程序筛查宫颈癌前病变[J]. 中国妇幼保健, 2011, 26(5): 769-770. |
| [52] | Fatahi Meybodi, N., Karimi-Zarchi, M., Allahqoli, L., et al. (2020) Accuracy of the Triple Test Versus Colposcopy for the Diagnosis of Premalignant and Malignant Cervical Lesions. Asian Pacific Journal of Cancer Prevention, 21, 3501-3507. https://doi.org/10.31557/APJCP.2020.21.12.3501 |
| [53] | Perkins, R.B., Guido, R.S., Castle, P.E., et al. (2020) 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease, 24, 102-131. https://doi.org/10.1097/LGT.0000000000000525 |
| [54] | 李军英, 冯相珍. 宫颈上皮内瘤变患者宫颈锥切术后病变残留和复发的列线图预测模型构建与评估[J]. 实用癌症杂志, 2023, 38(5): 834-838. |
| [55] | Soutter, W.P., Sasieni, P. and Panoskaltsis, T. (2006) Long-Term Risk of Invasive Cervical Cancer after Treatment of Squamous Cervical Intraepithelial Neoplasia. International Journal of Cancer, 118, 2048-2055. https://doi.org/10.1002/ijc.21604 |
